Fatigue News and Research

RSS

Health Union publishes RA in America 2013 survey results

Health Union, LLC announced today that it has published detailed results from the "RA in America 2013" survey on its newly launched website http://RheumatoidArthritis.Net. The survey covered a broad array of topics impacting people with Rheumatoid Arthritis (also called RA), and was taken by 1,055 respondents making it one of the largest of its kind conducted with RA patients in the United States.

28 Aug 2013

HCV treatment with sofosbuvir and ribavirin results in sustained virologic response

Treatment of chronic hepatitis C virus genotype 1 infection with the interferon-free regimen of sofosbuvir and ribavirin resulted in a high sustained virologic response rate in a patient population with unfavorable treatment characteristics, according to a study in the August 28 issue of JAMA.

28 Aug 2013

Tips from experts can help cancer survivors continue pre-diagnosis daily routines

A person is considered a cancer survivor from the minute they are diagnosed with the disease. Tips from experts at the University of Alabama at Birmingham (UAB) can help survivors continue pre-diagnosis daily routines that may include working; one such expert, a cancer survivor herself, experienced firsthand the benefits and challenges of survivorship in the workplace.

27 Aug 2013

tDCS for 15 days improves sleep and fatigue symptoms in patients with PPS

Of the 15 million people around the world who have survived poliomyelitis, up to 80% report progressive deteriorating strength and endurance many years after infection, a condition known as post-polio syndrome (PPS).

27 Aug 2013

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Takeda Pharmaceutical Company Limited today announced that results from two Phase 3 studies evaluating vedolizumab, an investigational humanized monoclonal antibody, for the treatment of adults with moderately to severely active ulcerative colitis and Crohn’s disease, were published in the August 22, 2013 issue of the New England Journal of Medicine.

22 Aug 2013

Pazopanib drug shows improved quality of life and safety in metastatic kidney cancer patients

Two oral targeted drugs approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, according to results of a large international clinical trial led by researchers at Dana-Farber Cancer Institute.

22 Aug 2013

Phase III trial evaluates impact of Wisconsin Ginseng on fatigue levels of cancer patients

Millions of cancer patients find themselves exhausted completing the most mundane of tasks, and extra sleep doesn't seem to help. Today, they find hope in a supplement that medical researchers have shown to be effective in boosting their energy levels: Wisconsin Ginseng.

20 Aug 2013

Second GSK intramuscular quadrivalent influenza vaccine approved by the FDA

GlaxoSmithKline plc [LSE/NYSE: GSK] announced that the U.S. Food and Drug Administration (FDA) has approved FLULAVAL® QUADRIVALENT (Influenza Virus Vaccine) for the active immunization of persons three years of age and older to help prevent disease caused by seasonal influenza (flu) virus subtypes A and B contained in the vaccine.

19 Aug 2013

Study provides information that validates genetic basis of adaptation to high altitudes

Research led by scientists from the University of California, San Diego has decoded the genetic basis of chronic mountain sickness (CMS) or Monge's disease. Their study provides important information that validates the genetic basis of adaptation to high altitudes, and provides potential targets for CMS treatment.

16 Aug 2013

Hypnotic relaxation therapy improves sexual health in postmenopausal women

Hypnotic relaxation therapy improves sexual health in postmenopausal women who have moderate to severe hot flashes, according to Baylor University researchers who presented their findings at the American Psychological Association's recent annual meeting.

16 Aug 2013

Scientists uncover potential drug target for effective therapy against bacterial disease brucellosis

UC Davis scientists have uncovered a potential drug target for the development of an effective therapy against the debilitating, chronic form of the bacterial disease brucellosis, which primarily afflicts people in Mediterranean and Middle Eastern countries.

16 Aug 2013

Preventive antibiotics for HIV patients lower risk of TB or death

As part of the largest international research effort ever made to combat tuberculosis, a team of Johns Hopkins and Brazilian experts has found that preventive antibiotic therapy for people with HIV lowers this group's chances of developing TB or dying.

16 Aug 2013

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.

15 Aug 2013

Early surgery offers long-term survival, lowers risk of heart failure in mitral valve regurgitation patients

Patients with severe mitral valve regurgitation who are otherwise healthy should have mitral valve repair surgery sooner rather than later, even if they feel no symptoms, a Mayo Clinic-led study by U.S. and European researchers found.

14 Aug 2013

Student explores how truck drivers react to marketplace demands for flexibility, speed

Benjamin Snyder conducted his research in the cab of a truck hauling frozen chicken from Missouri to Virginia. Snyder, a graduate sociology student in the University of Virginia's Graduate School of Arts & Sciences, will present his paper, "The Professionalized Body: Truck Driving in the Age of Flexibilization," at the 108th Annual Meeting of the American Sociological Association.

13 Aug 2013

Quality of life of young, female cancer survivors is impaired after treatment

A new study led by a University of Colorado Cancer Center member recently published in the journal Quality of Life Research reveals that in young, female cancer survivors, quality of life is significantly impaired long after treatment. The study compared 59 cancer survivors to 66 healthy controls and found that, as expected, cancer survivors showed higher stress and anxiety than the general population.

13 Aug 2013

Harvard University receives grant to use organs-on-chips device to test human response to radiation

A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has received a $5.6 million grant award from the United States Food and Drug Administration (FDA) to use its Organs-on-Chips technology for a novel application of keen interest to national security and health officials: to test human physiological responses to radiation, and to evaluate drugs designed to counter those effects.

13 Aug 2013

Johns Hopkins University receives $5.8M grant to research on causes of frailty in older adults

The federal government has awarded investigators at The Johns Hopkins University's schools of medicine and public health a multimillion-dollar, five-year grant to continue research designed to identify the causes of frailty in older adults, and speed the development of interventions to slow or stop it.

7 Aug 2013

Meridian Health earns Chest Pain Center Accreditation

Meridian Health, a leading New Jersey health care system, has recently earned the highest designated Chest Pain Center Accreditation by the Society of Cardiovascular Patient Care, a global not-for-profit organization committed to leading the fight to eliminate heart disease as the number one cause of death worldwide.

6 Aug 2013

Study shows role of love hormone in promoting social and parental bonding

In a loud, crowded restaurant, having the ability to focus on the people and conversation at your own table is critical. Nerve cells in the brain face similar challenges in separating wanted messages from background chatter.

6 Aug 2013

Fatigue News and Research

Health Union publishes RA in America 2013 survey results

HCV treatment with sofosbuvir and ribavirin results in sustained virologic response

Tips from experts can help cancer survivors continue pre-diagnosis daily routines

tDCS for 15 days improves sleep and fatigue symptoms in patients with PPS

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Pazopanib drug shows improved quality of life and safety in metastatic kidney cancer patients

Phase III trial evaluates impact of Wisconsin Ginseng on fatigue levels of cancer patients

Second GSK intramuscular quadrivalent influenza vaccine approved by the FDA

Study provides information that validates genetic basis of adaptation to high altitudes

Hypnotic relaxation therapy improves sexual health in postmenopausal women

Scientists uncover potential drug target for effective therapy against bacterial disease brucellosis

Preventive antibiotics for HIV patients lower risk of TB or death

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Early surgery offers long-term survival, lowers risk of heart failure in mitral valve regurgitation patients

Student explores how truck drivers react to marketplace demands for flexibility, speed

Quality of life of young, female cancer survivors is impaired after treatment

Harvard University receives grant to use organs-on-chips device to test human response to radiation

Johns Hopkins University receives $5.8M grant to research on causes of frailty in older adults

Meridian Health earns Chest Pain Center Accreditation

Study shows role of love hormone in promoting social and parental bonding

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News